Quarterly Revenue Growth and Market Wins
Consolidated revenue grew 5.1% in Q4 2025 vs prior year, driven by double-digit growth in key end markets and new contract wins (e.g., Bechtel/Woodside LNG project and data center engagements). Aerospace & defense grew $4.5M (+21.9% Q/QY), power generation grew $3.3M (+33.2% Q/QY), industrials +6.7% and infrastructure +26.8% in the quarter.
Record Q4 Adjusted EBITDA and Margin Expansion
Q4 adjusted EBITDA was $24.8M, up 18.2% year-over-year, with an adjusted EBITDA margin of 13.7%, a 160 basis point improvement versus prior-year quarter — the highest Q4 adjusted EBITDA and margin in company history.
Significant Laboratory and Data Solutions Performance
Laboratories business delivered a record performance in Q4 with a 661% increase vs prior year. Data Solutions / PCMS offerings grew 20.7% in 2025 and 25.2% year-over-year for the full year, highlighting growing recurring revenue from software/analytics.
Gross Profit and Full-Year EBITDA Record
Full year gross profit increased to nearly $205.0M (+6.4% YoY) with a 190 basis point improvement in gross margin to 28.4%. Full-year adjusted EBITDA was a company record at $91.1M with an EBITDA margin of 12.6%, exceeding prior outlook.
Returned to Positive Free Cash Flow and Strengthened Liquidity Position
Management delivered positive free cash flow in 2025 and generated cash from operations in the year. Net debt improved slightly to $150.0M (down $1.3M YoY) and bank-defined leverage remained well within covenant at ~2.5x (below 3.75x), with a stated plan to reduce leverage to ~2.0x in 2026 via targeted $20M paydown.
Clear 2026 Guidance and Strategic Roadmap
Management provided a 2026 outlook: revenue $730M–$750M and adjusted EBITDA $91M–$93M, clarified a targeted CapEx increase to ~4.5% of revenue to remove capacity constraints (particularly in in-lab aerospace & defense) and reiterated longer-term goals of ~5% CAGR to 2030 and a ~15% target EBITDA margin.